Attys Agree To $143M Fee Split In $2.3B Avandia MDL

Law360, New York (January 22, 2013, 7:19 PM EST) -- Plaintiffs' attorneys on Thursday filed a plan in Pennsylvania federal court to split $143 million to resolve a fee dispute in what could be a $2.3 billion settlement in a massive multidistrict litigation over GlaxoSmithKline PLC's alleged failure to warn consumers about health risks related to its diabetes drug Avandia.

The judge overseeing the case had appointed a committee of eight attorneys who had worked on the case to come up with a fee allocation plan for the 58 lawyers and firms who had earned some...
To view the full article, register now.